West Pharmaceutical Services Inc (NYSE:WST) — Stock Price
West Pharmaceutical Services Inc (NYSE:WST) is currently trading at $352.13 USD, down 0.55% today. Over the past 52 weeks, shares have ranged between $230.95 and $365.74. This page tracks West Pharmaceutical Services Inc's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see West Pharmaceutical Services Inc (WST) market capitalisation.
West Pharmaceutical Services Inc (WST) Stock Price Chart — Daily History & Trading Volume
The chart below tracks West Pharmaceutical Services Inc's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
West Pharmaceutical Services Inc Income Statement — Revenue, Profit & Earnings by Year
West Pharmaceutical Services Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $3.07 Billion | $2.89 Billion | $2.95 Billion | $2.89 Billion | $2.83 Billion |
| Cost of Revenue | $1.97 Billion | $1.89 Billion | $1.82 Billion | $1.75 Billion | $1.66 Billion |
| Gross Profit | $1.10 Billion | $1.00 Billion | $1.13 Billion | $1.14 Billion | $1.17 Billion |
| Research & Development | $74.30 Million | $69.10 Million | $68.40 Million | $58.50 Million | $52.80 Million |
| SG&A | $388.70 Million | $338.50 Million | $353.40 Million | $343.70 Million | $362.80 Million |
| Total Operating Expenses | $485.90 Million | $407.60 Million | $421.80 Million | $375.40 Million | $414.70 Million |
| Operating Income | $617.40 Million | $594.60 Million | $710.90 Million | $763.50 Million | $758.70 Million |
| EBITDA | $723.60 Million | $743.80 Million | $844.10 Million | $808.10 Million | $879.70 Million |
| EBIT | $599.20 Million | $588.40 Million | $706.80 Million | $687.50 Million | $757.40 Million |
| Interest Expense | $600.00K | $2.90 Million | $8.80 Million | $7.60 Million | $8.50 Million |
| Income Before Tax | $615.30 Million | $600.20 Million | $715.70 Million | $700.60 Million | $769.00 Million |
| Income Tax Expense | $121.60 Million | $107.50 Million | $122.30 Million | $114.70 Million | $107.20 Million |
| Net Income | $493.70 Million | $492.70 Million | $593.40 Million | $585.90 Million | $661.80 Million |
West Pharmaceutical Services Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes West Pharmaceutical Services Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $4.27 Billion | $3.64 Billion | $3.83 Billion | $3.62 Billion | $3.31 Billion |
| Total Current Assets | $1.98 Billion | $1.54 Billion | $1.94 Billion | $1.92 Billion | $1.74 Billion |
| Cash & Equivalents | $791.30 Million | $484.60 Million | $853.90 Million | $894.30 Million | $762.60 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $574.40 Million | $552.50 Million | $512.00 Million | $507.40 Million | $489.00 Million |
| Inventory | $443.90 Million | $377.00 Million | $434.70 Million | $414.80 Million | $378.40 Million |
| Property, Plant & Equipment | $1.84 Billion | $1.72 Billion | $1.51 Billion | $1.16 Billion | $1.06 Billion |
| Goodwill | $109.90 Million | $106.10 Million | $108.50 Million | $107.30 Million | $109.90 Million |
| Total Liabilities | $1.09 Billion | $961.10 Million | $948.50 Million | $931.90 Million | $978.40 Million |
| Total Current Liabilities | $654.90 Million | $550.40 Million | $671.80 Million | $519.00 Million | $594.10 Million |
| Long-term Debt | $202.80 Million | $202.60 Million | $72.80 Million | $206.70 Million | $208.80 Million |
| Net Debt | $-374.60 Million | $-179.30 Million | $-544.90 Million | $-576.40 Million | $-437.30 Million |
| Total Stockholder Equity | $3.18 Billion | $2.68 Billion | $2.88 Billion | $2.68 Billion | $2.34 Billion |
| Retained Earnings | $4.37 Billion | $3.96 Billion | $3.52 Billion | $2.99 Billion | $2.46 Billion |
West Pharmaceutical Services Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how West Pharmaceutical Services Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $754.80 Million | $653.40 Million | $776.50 Million | $724.00 Million | $584.00 Million |
| Capital Expenditures | $285.90 Million | $377.00 Million | $362.00 Million | $284.60 Million | $253.40 Million |
| Free Cash Flow | $468.90 Million | $276.40 Million | $414.50 Million | $439.40 Million | $330.60 Million |
| Investing Cash Flow | $-285.90 Million | $-378.70 Million | $-368.70 Million | $-288.20 Million | $-253.10 Million |
| Financing Cash Flow | $-185.10 Million | $-622.60 Million | $-459.60 Million | $-293.60 Million | $-168.10 Million |
| Dividends Paid | $-61.20 Million | $-59.10 Million | $-57.00 Million | $54.10 Million | $51.10 Million |
| Stock-Based Compensation | $23.80 Million | $18.70 Million | $23.30 Million | $23.70 Million | $37.50 Million |
| Depreciation | $168.60 Million | $155.40 Million | $137.30 Million | $120.60 Million | $122.30 Million |
| Change in Cash | $306.70 Million | $-369.30 Million | $-40.40 Million | $131.70 Million | $147.10 Million |
West Pharmaceutical Services Inc Earnings History — EPS Actual vs. Analyst Estimates
Track West Pharmaceutical Services Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 23, 2026 | — | 2.08 | — |
| Apr 23, 2026 | 2.13 | 1.68 | +26.79% |
| Feb 12, 2026 | 2.04 | 1.83 | +11.48% |
| Oct 23, 2025 | 1.92 | 1.67 | +14.97% |
| Jul 24, 2025 | 1.84 | 1.54 | +19.48% |
| Apr 24, 2025 | 1.45 | 1.26 | +15.08% |
| Feb 13, 2025 | 1.82 | 1.71 | +6.43% |
| Oct 24, 2024 | 1.85 | 1.46 | +26.71% |